Law Firm | Canadian Lawyer

GlycoBioSciences Inc.

Hearing Date: 15 Oct 2024

GlycoBioSciences Inc. (Glyco) v. MAGNA Pharmaceuticals, Inc. (Magna)

CourtCourt of Appeal for Ontario

Case NumberM55197; M55199; COA-24-CV-0270; COA-24-CV-0417

Practice AreaCorporate & commercial law

ClientsGlycoBioSciences Inc. (“Glyco”), MAGNA Pharmaceuticals, Inc. (“Magna”), Industria Farmaceutica Andromaco, SA., de C.V. (“Andromaco”), Montebello Packaging (“Montebello”), Nadro S.A.P.I. de C.V. (“Nadro”)
Hearing Date: 24 Jul 2024

Glycobiosciences Inc. v. Magna Pharmaceuticals Inc.

CourtSuperior Court of Justice - Ontario

Case NumberCV-24-00000097-0000

Practice AreaIntellectual property

ClientsGLYCOBIOSCIENCES INC., MAGNA PHARMACEUTICALS INC., ROBERT VAN
Hearing Date: 28 Jun 2024

GLYCOBIOSCIENCES INC. v. L’OREAL CANADA INC.

CourtSuperior Court of Justice - Ontario

Case NumberCV-24-00000040-0000

Practice AreaCorporate & commercial law

ClientsGLYCOBIOSCIENCES INC., L’OREAL CANADA INC., LENCZNER SLAUGHT LLP

Showing 1 to 3 of 3 entries

1

MOST ACTIVE FIRMS

01

Gowling WLG (Canada) LLP

Case 263 | Deals 78

02

McCarthy Tétrault LLP

Case 227 | Deals 295

03

Borden Ladner Gervais LLP (BLG)

Case 209 | Deals 119

04

Fasken Martineau DuMoulin LLP

Case 190 | Deals 190

05

Miller Thomson LLP

Case 165 | Deals 54

RECENTLY ADDED DEALS

09 Dec 2024

Freehold Royalties Ltd. announces $150 million equity offering to fund Midland Basin acquisition

08 Dec 2024

Fortis Inc. announces $500 million equity offering

08 Dec 2024

Lundin Mining to sell Neves-Corvo and Zinkgruvan operations to Boliden for up to US$1.52 billion

05 Dec 2024

KisoJi raises $57 million in Series B financing

05 Dec 2024

Organigram acquires Motif, becoming Canada's largest cannabis firm by market share